Paula Boultbee
Président chez The Max Foundation
Provenance du réseau au premier degré de Paula Boultbee
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Maxaid
 Maxaid Miscellaneous Commercial ServicesCommercial Services Maxaid is a non-profit organization that provides healthcare services. The non-profit company is based in Seattle, WA.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paula Boultbee via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BIOMEA FUSION, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| SUMMIT THERAPEUTICS INC. | Biotechnology | Director of Finance/CFO Director/Board Member General Counsel Chief Tech/Sci/R&D Officer | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Compliance Officer | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Chalmers University of Technology | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree | |
| University of Gothenburg | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
| PULSE BIOSCIENCES, INC. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of California, Santa Barbara | College/University | Graduate Degree Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Graduate Degree Doctorate Degree | |
| Hamilton College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
Onward Therapeutics SA
 Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Biotechnology | Founder | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Acerta Pharma LLC | Chief Operating Officer | ||
| ARAVIVE, INC. | Biotechnology | Director of Finance/CFO | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member | |
| NANOBIOTIX | Medical Specialties | Director/Board Member | |
EMERCell SAS
 EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed. | Pharmaceuticals: Major | Director/Board Member | |
| Chiron Therapeutics, Inc. | Corporate Officer/Principal | ||
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Operating Officer | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| Fondation A.R.CA.D. | Investment Trusts/Mutual Funds | Director/Board Member | |
Alain Oncologie Consulting
 Alain Oncologie Consulting Miscellaneous Commercial ServicesCommercial Services Alain Oncologie Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ad Bio Consulting
 Ad Bio Consulting Miscellaneous Commercial ServicesCommercial Services Ad Bio Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 33 |
| France | 8 |
| Royaume-Uni | 3 |
| Suède | 3 |
| Belgique | 3 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 123 |
| Corporate Officer/Principal | 99 |
| Chief Tech/Sci/R&D Officer | 39 |
| Independent Dir/Board Member | 34 |
| Chairman | 33 |
Relations les plus connectées
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| Anna Belfrage | 23 |
| Jan-Eric Österlund | 20 |
| Lennart Christer Jeansson | 20 |
| Jan Birger Fredrik Toernell | 19 |
| Jan Anders Vedin | 19 |
| Alain Herrera | 17 |
| Maria Fardis | 15 |
| Manmeet Singh Soni | 13 |
| Elizabeth Faust | 12 |
| Elaine C. Stracker | 12 |
| Aram Andrew Mangasarian | 11 |
| Joshua Brumm | 11 |
| Pär-Ola Mannefred | 11 |
| Gregory R. Wade | 10 |
- Bourse
- Insiders
- Paula Boultbee
- Connexions Sociétés
